• IMA sites
  • IMAJ services
  • IMA journals
  • Follow us
  • Alternate Text Alternate Text
עמוד בית
Wed, 24.07.24

CASE COMMUNICATION

IMAJ | volume 25

Journal 11, November 2023
pages: 760-762

Immediate Improvement after Thymoma Resection in a Young Refractory Myasthenia Gravis Patient: A Case Report

1 Department of Neurology, Sheba Medical Center, Tel Hashomer, Israel 2 Department of Neurology, Mayo Clinic, Rochester, MN, USA 3 Department of Neurology, Rambam Health Care Campus, Haifa, Israel 4 Neuroimmunology Laboratory, Rappaport Faculty of Medicine, Technion–Israel Institute of Technology, Haifa, Israel

Summary

In the acute settings of generalized myasthenia gravis (MG) treatment options include plasma exchange (PLEX), intravenous immunoglobulin (IVIG), and pyridostigmines. A thymoma is associated with the disease in up to 20% of cases [1,2].

In cases where a thymoma is detected, surgical treatment to remove the tumor is recommended in certain age groups. At present, there are no clear guidelines regarding the optimal time to perform thymectomy after diagnosis of acute crisis or from the last treatment to thymectomy. Treatment is at the clinician's discretion.

Legal Disclaimer: The information contained in this website is provided for informational purposes only, and should not be construed as legal or medical advice on any matter.
The IMA is not responsible for and expressly disclaims liability for damages of any kind arising from the use of or reliance on information contained within the site.
© All rights to information on this site are reserved and are the property of the Israeli Medical Association. Privacy policy

2 Twin Towers, 35 Jabotinsky, POB 4292, Ramat Gan 5251108 Israel